Low dietary inorganic phosphate stimulates lung tumorigenesis through altering protein translation and cell cycle in K-rasLA1 mice

Nutrition and Cancer

Volumn 62, Issue 4, 2010, Pages 525-532

  Xu, Cheng Xiong ^a,b   Jin, Hua ^c   Lim, Hwang Tae ^a   Ha, Yoon Cheol ^a   Chae, Chan Hee ^a   An, Gil Hwan ^d   Lee, Kee Ho ^e   Cho, Myung Haing ^a,f  

^a Seoul National University   (South Korea)

^b EMORY UNIVERSITY   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Chungnam National University   (South Korea)

^e Korea Institute of Radiation and Medical Science   (South Korea)

^f National Core Research Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D3; INITIATION FACTOR 4E BINDING PROTEIN 1; K RAS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; S6 KINASE; SODIUM PHOSPHATE COTRANSPORTER 2B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME ACTIVATION; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PHOSPHATE INTAKE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADENOMA; ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; GENES, RAS; HYPERPLASIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MICE; PHOSPHOPROTEINS; PHOSPHORUS, DIETARY; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RANDOM ALLOCATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB; TUMOR BURDEN;

MUS;

EID: 77951979923     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903532432     Document Type: Article

References (40)

1. Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, et al.: Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 8, 191-200, 2004.
2. Xu CX, Jin H, Lim HT, Kim JE, Shin JY, et al.: High dietary inorganic phosphate enhances cap-dependent protein translation, cell cycle progression, and angiogenesis in the livers of young mice. Am J Physiol Gastrointest Liver Physiol 295, G654-G663, 2008.
3. Jin H, Chang SH, Xu CX, Shin JY, Chung YS, et al.: High dietary inorganic phosphate affects lung through altering protein translation, cell cycle, and angiogenesis in developing mice. Toxicol Sci 100, 215-223, 2007.
4. Jin H, Hwang SK, Yu K, Anderson HK, Lee YS, et al.: A high inorganic phosphate diet perturbs brain growth, alters Akt-ERK signaling, and results in changes in cap-dependent translation. Toxicol Sci 90, 221-229, 2006.
5. Weiner ML, Salminen WF, Larson PR, Barter RA, Kranetz JL, et al.: Toxicological review of inorganic phosphates. Food Chem Toxicol 39, 759-786, 2001.
6. Jin H, Xu CX, Lim HT, Park SJ, Shin JY, et al.: High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med 179, 59-68, 2009.
7. Hashimoto M, Wang DY, Kamo T, Zhu Y, Tsujiuchi T, et al.: Isolation and localization of type IIb Na/Pi cotransporter in the developing rat lung. Am J Pathol 157, 21-27, 2000.
8. Yin BW, Kiyamova R, Chua R, Caballero OL, Gout I, et al.: Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas. Cancer Immun 8, 3, 2008.
9. Tang JM, He QY, Guo RX, and Chang XJ: Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 51, 181-191, 2006.
10. Takeda E, Taketani Y, Sawada N, Sato T, and Yamamoto H: The regulation and function of phosphate in the human body. Biofactors 21, 345-355, 2004.
11. Jin H, Hwang SK, Kwon JT, Lee YS, An GH, et al.: Low dietary inorganic phosphate affects the brain by controlling apoptosis, cell cycle and protein translation. J Nutr Biochem 19, 16-25, 2008.
12. Malkinson AM: Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 32, 265-279, 2001.
13. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al.: Somatic activation of the K-ras oncogene causes early-onset lung cancer in mice. Nature 410, 1111-1116, 2001.
14. Fuller SA, Takahashi M, and Hurrell J G G: Preparation of monoclonal antibodies. In: Current Protocols in Molecular Biology, Ausubel FM, Brent R, Kingston RE, More DD, Seidman JG, et al. (eds.). New York:Wiley, 2007, pp. 11.4.1-.5.
15. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, et al.: A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 60, 901-907, 2000.
16. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, et al.: Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111, 81-90, 2003.
17. Suzuki O, Kamakura S, Katagiri T, Nakamura M, Zhao B, et al.: Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27, 2671-2681, 2006.
18. Czarnogorski M, Woda CB, Schulkin J, and Mulroney SE: Induction of a phosphate appetite in adult male and female rats. Exp Biol Med (Maywood) 229, 914-919, 2004.
19. Marks KH, Kilav R, Berman E, Naveh-Many T, and Silver J: Parathyroid hormone gene expression in Hyp mice fed a low-phosphate diet. Nephrol Dial Transplant 12, 1581-1585, 1997.
20. Ohnishi R, Segawa H, Kawakami E, Furutani J, Ito M, et al.: Control of phosphate appetite in young rats. J Med Invest 54, 366-369, 2007.
21. Caverzasio J and Bonjour JP: Characteristics and regulation of Pi transport in osteogenic cells for bone metabolism. Kidney Int 49, 975-980, 1996.
22. Hattenhauer O, Traebert M, Murer H, and Biber J: Regulation of small intestinal Na-P (i) type IIb cotransporter by dietary phosphate intake. Am J Physiol 277, G756-G762, 1999.
23. Loghman-Adham M: Adaptation to changes in dietary phosphorus intake in health and in renal failure. J Lab Clin Med 129, 176-188, 1997.
24. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, et al.: Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1, 25-dihydroxyvitamin D metabolism in mice. Endocrinology 146, 5358-5364, 2005.
25. Traebert M, Hattenhauer O, Murer H, Kaissling B, and Biber J: Expression of type II Na-P (i) cotransporter in alveolar type II cells. Am J Physiol 277, L868-L873, 1999.
26. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2, 489-501, 2002.
27. Xu CX, Jin H, Chung YS, Shin JY, Hwang SK, et al.: Low dietary inorganic phosphate affects lung growth of developing mice. J Vet Sci 10, 105-113, 2009.
28. Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, et al.: Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res 68, 1119-11127, 2008.
29. Jin H, Xu CX, Kim HW, Chung YS, Shin JY, et al.: Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras (LA1) mice. Cancer Gene Ther 15, 275-283, 2008.
30. Mamane Y, Petroulakis E, LeBacquer O, and Sonenberg N: mTOR, translation initiation and cancer. Oncogene 25, 6416-6422, 2006.
31. Nave BT, Ouwens M, Withers DJ, Alessi DR, and Shepherd PR: Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344, 427-431, 1999.
32. Wislez M, Loreto Spencer M, Izzo JG, Juroske DM, Balhara K, et al.: Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 65, 3226-3235, 2005.
33. Fumarola C, La Monica S, Alfieri RR, Borra E, and Guidotti GG: Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis. Cell Death Differ 12, 1344-1357, 2005.
34. Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, et al.: Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107, 1801-1811, 2006.
35. Fingar DC, Salama S, Tsou C, Harlow E, and Blenis J: Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16, 1472-1487, 2002.
36. Costa LJ: Aspects of mTOR biology and the use of mTOR inhibitors in non-Hodgkin's lymphoma. Cancer Treat Rev 33, 78-84, 2007.
37. Coqueret O: Linking cyclins to transcriptional control. Gene 299, 35-55, 2002.
38. Lin L, Wang Y, Bergman G, Kelloff GJ, Lubet RA, et al.: Detection of differentially expressed genes in mouse lung adenocarcinomas. Exp Lung Res 27, 217-229. 2001.
39. Gautschi O, Ratschiller D, Gugger M, Betticher DC, and Heighway J: Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55, 1-14, 2007.
40. Betticher DC, Heighway J, Thatcher N, and Hasleton PS: Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 75, 1761-1768, 1997.